Here’s the number that anchors this entire conversation: NAD+ levels decline by approximately 60% between young adulthood and middle age. That’s not a marginal dip it’s a collapse in one of the most fundamental coenzymes in human cell biology, and it has measurable consequences for virtually every tissue in your body, including your skin.
The question isn’t whether NAD+ decline matters for aging. It does. The question is whether supplementing with NAD+ precursors through IV infusions, oral NMN, or NR capsules meaningfully reverses skin aging in living humans. And that’s where the evidence is more nuanced than the supplement industry and the wellness clinic marketing landscape would have you believe.
Here’s the honest, complete picture: what NAD+ does, what the 2025–2026 research actually shows, and where the science is genuinely heading.
What NAD+ Does in Skin Cells
NAD+ (nicotinamide adenine dinucleotide) is not a vitamin or a hormone it’s a coenzyme present in every living cell, essential to the processes that keep cells alive, functional, and capable of repair. In skin specifically, NAD+ serves several critical roles:
Energy production: NAD+ is a central player in cellular respiration the process by which mitochondria convert nutrients into ATP. Skin cells, particularly fibroblasts (the cells that produce collagen and elastin) and keratinocytes (the outer barrier cells), require continuous ATP production. As NAD+ levels decline with age, mitochondrial function in skin cells becomes less efficient.
DNA repair: When UV radiation, oxidative stress, or environmental pollution damages DNA in skin cells, a family of enzymes called PARPs (poly ADP ribose polymerases) uses NAD+ as fuel to initiate repair. Without adequate NAD+, damaged DNA accumulates contributing to cellular dysfunction, inflammation, and the cellular senescence that drives visible skin aging.
Sirtuin activation: Sirtuins are a family of proteins (SIRT1 7) that regulate gene expression, cellular stress responses, and inflammation. They require NAD+ to function without it, they’re essentially inactive. Sirtuins have been shown to suppress inflammatory pathways in skin cells, reduce oxidative damage, and influence collagen metabolism. Their age related decline is directly tied to falling NAD+ levels.
Collagen synthesis support: Fibroblasts produce collagen using energy and regulatory signals that depend on NAD+ dependent pathways. When NAD+ is depleted, fibroblast function declines and with it, the rate of collagen and elastin production.
The mechanism is biologically coherent and well supported. The gap the one that matters for clinical decisions is between this clear mechanistic story and the question of whether restoring NAD+ in a living person changes visible skin outcomes.
What the 2025–2026 Research Actually Shows
The research picture is more complex than either enthusiastic boosters or dismissive critics suggest. Here’s an accurate tier by tier breakdown:
Tier 1 Strong pre clinical (cell and animal) evidence:
An October 2025 study on human skin fibroblasts found that NMN (nicotinamide mononucleotide an NAD+ precursor) reduced markers of aging, restored collagen levels, and activated repair pathways more effectively than NR and other precursors in laboratory conditions. Most compellingly: even after NMN treatment stopped, cells maintained higher collagen levels for more than 10 days suggesting lasting cellular adaptation, not just acute supplementation effects. The researchers found NMN outperformed other precursors in wound healing speed, DNA repair activation, and mitochondrial function restoration in stressed skin cells.
A 2025 UV B photoaging mouse model found that oral NMN at doses of 100–300 mg/kg daily led to lower wrinkle depth, better skin hydration, and improved elasticity compared to controls.
These are compelling findings. They describe a plausible, real mechanism. They are not human clinical trial results.
Tier 2 Limited but important human evidence:
The most significant human study specifically relevant to skin was published in Aging Cell in June 2025 by researchers from Chiba University. The double blind trial used NR (nicotinamide riboside another NAD+ precursor) in patients with Werner syndrome, a rare genetic condition that causes severe premature aging. Results showed NR reduced skin ulcers, improved cardiovascular markers, and protected kidney function. While Werner syndrome is not standard aging, it provides the closest validated human evidence that NAD+ restoration through oral NR can support skin tissue integrity.
Separately, a January 2026 Nature Metabolism trial directly compared three NAD+ precursors in humans: NR, NMN, and Nam (nicotinamide). The finding: both NR and NMN significantly raised blood NAD+ levels over 14 days of supplementation, while Nam had no significant impact. This established that NR and NMN are demonstrably superior to regular nicotinamide for actually increasing NAD+ a foundational pharmacokinetic fact for anyone choosing between these options.
Tier 3 The honest gap:
A February 2026 systematic review in ScienceDirect analyzed 113 eligible studies (33 human trials). Its conclusion, quoted directly in paraphrase: dermatologic aging outcomes were rarely assessed in humans. Critically: no eligible human trials in the dataset evaluated intravenous or intramuscular NAD+ specifically for skin aging or aesthetic outcomes.
This is the most important fact for people considering IV NAD+ therapy specifically for skin the most direct delivery method has not yet been tested in randomized, controlled human trials for skin aging endpoints. The safety data is favorable (intravenous NMN studies showed no acute abnormalities), but efficacy for skin specifically remains to be established through rigorous human trials.
The Delivery Method Question: Oral vs. IV
For anyone interested in NAD+ for skin, the delivery method question is clinically relevant.
Oral NMN or NR supplements are the most studied route. They raise blood NAD+ levels measurably (NR and NMN, not Nam per the January 2026 Nature Metabolism trial). Whether that blood level increase translates into meaningful tissue level NAD+ restoration in skin specifically depends on how efficiently skin cells absorb circulating NAD+ precursors a question still under investigation.
IV NAD+ infusions bypass digestive metabolism and deliver NAD+ (or NMN) directly to the bloodstream, producing more rapid and significant elevation in circulating levels. The safety profile of IV infusions is favorable in the studies conducted. IV NAD+ is already used in clinical settings for cellular energy support, neurological recovery protocols, and metabolic function and NAD+ IV therapy benefits, risks, and who it’s for covers those applications in detail.
For skin aging specifically, the reasonable hypothesis is that higher bioavailability through IV delivery would provide greater cellular NAD+ restoration than oral supplementation but this hypothesis hasn’t been tested in a skin outcome specific human trial. The evidence based path is to understand this gap rather than oversell the application.
Who Is Most Likely to Benefit
Based on the current evidence base, the populations most likely to see meaningful benefit from NAD+ restoration strategies include:
- Adults over 40 where the 60% NAD+ decline from young adulthood is most pronounced and the downstream cellular effects most clinically significant
- People with high sun exposure history UV damage is specifically NAD+ depleting through PARP activation, meaning those with significant photoaging may have especially depleted skin cell NAD+ reserves
- Women in perimenopause and post menopause declining estrogen compounds cellular energy decline, and NAD+ dependent sirtuin activity intersects with the same pathways affected by hormonal transition. Weight gain during perimenopause and HRT for women are companion topics where cellular energy metabolism is equally relevant.
- People experiencing chronic stress or sleep disruption both deplete NAD+ through elevated PARP activation and increased oxidative stress burden. How sleep affects your hormones and cellular energy production are directly connected.
What NAD+ Can and Cannot Do for Skin in Plain Terms
What the evidence supports:
- NAD+ decline with age is real, measurable, and mechanistically relevant to skin aging
- NMN and NR (but not standard nicotinamide) raise blood NAD+ levels in humans
- NMN outperforms NR in skin cell laboratory models for collagen restoration, DNA repair activation, and wound healing
- Oral NMN/NR supplementation is safe in clinical studies to date
- IV NAD+ delivery is safe in the limited studies conducted
What the evidence does not yet support:
- Direct evidence that IV or oral NAD+ supplementation reverses visible skin aging (wrinkles, elasticity) in randomized, controlled human trials
- Established dosing protocols specifically for skin outcomes in living humans
- Any single NAD+ product’s superiority for skin outcomes in real world clinical settings
This is a genuinely promising area of aging research. The gap between pre clinical evidence and human clinical outcomes is smaller than it was three years ago and the Werner syndrome trial represents meaningful progress. But responsible communication about NAD+ and skin aging means holding both truths simultaneously: compelling mechanism, still incomplete human evidence.
IV vitamin therapy for fatigue and cellular support and collagen supplements what actually works are complementary reads for anyone building a comprehensive skin aging strategy.
Conclusion: Real Science, Honest Expectations, Real Possibility
NAD+ and skin aging is not hype. The biology is real, the pre clinical data is consistent, and the 2025–2026 human research is beginning to close the gap between lab findings and clinical outcomes. But “promising” and “proven” are different words and any clinic or supplement brand that doesn’t acknowledge that distinction is prioritizing sales over your informed decision making.
The intelligent approach: understand the mechanism, choose evidence supported NAD+ precursors (NMN or NR, not Nam), consider IV delivery for enhanced bioavailability, combine this with the proven foundational strategies (sunscreen, collagen precursors, sleep, stress management), and stay open to the human clinical evidence that is actively developing.
At AK Twisted Wellness, we offer IV NAD+ therapy as part of a comprehensive cellular wellness approach honest about what the evidence supports and transparent about where it’s still evolving. We contextualize NAD+ alongside the hormonal and metabolic picture that determines how well any cellular intervention actually works.
Visit aktw.life or call (520) 710 8805 telehealth and in clinic IV therapy available.
Frequently Asked Questions
1. Does NAD+ really help with skin aging? NAD+ plays critical roles in skin cell energy production, DNA repair, and collagen synthesis and its decline by approximately 60% between young adulthood and middle age is mechanistically linked to skin aging. Pre clinical evidence (including October 2025 human fibroblast studies) shows NMN restores collagen production and activates repair pathways in stressed skin cells. However, no large, well controlled human clinical trials have yet demonstrated visible wrinkle reduction or elasticity improvement from oral or IV NAD+ supplementation. The mechanism is sound; the human clinical proof is still in progress.
2. Is NMN or NR better for skin aging? Based on the October 2025 human skin fibroblast study, NMN outperformed NR and other NAD+ precursors for collagen restoration, DNA repair activation, and wound healing in stressed skin cells. The January 2026 Nature Metabolism head to head human trial confirmed both NMN and NR raise blood NAD+ levels (unlike standard nicotinamide), with similar efficacy for blood level increase. For skin specific outcomes, the cell biology favors NMN but this hasn’t been directly compared in a skin aging human trial.
3. Is IV NAD+ better than oral supplements for skin? IV NAD+ delivers higher bioavailability to the bloodstream, bypassing digestive metabolism. The safety profile of IV administration is favorable in studies to date. For systemic cellular energy and neurological applications, the higher peak blood levels from IV delivery are generally considered advantageous. For skin aging specifically, no human trial has directly compared IV versus oral NAD+ on skin outcomes so the superiority of IV for skin is a reasonable hypothesis, not yet a proven clinical fact.
4. How much NAD+ decline happens with age? NAD+ levels decline by approximately 60% between young adulthood and middle age across multiple tissue types including skin, blood, muscle, liver, and brain. This decline is considered a hallmark of aging by researchers in the longevity field contributing to reduced cellular energy production, impaired DNA repair, reduced sirtuin activity, and increased inflammatory burden in aging tissues.
5. Who should consider NAD+ therapy for skin health? Adults over 40 with visible signs of skin aging, significant UV exposure history, high chronic stress burden, or sleep disruption are the most likely to have meaningfully depleted NAD+ levels and potentially benefit from restoration. Women in perimenopause and post menopause face compounding cellular energy challenges that NAD+ dependent pathways directly affect. NAD+ therapy is most rationally used as part of a comprehensive skin health strategy that includes sun protection, collagen support, hormonal optimization where relevant, and established skincare ingredients.
6. How does AK Twisted Wellness approach NAD+ for skin aging? We offer IV NAD+ therapy as part of our cellular wellness protocols understanding its current evidence base accurately and contextualizing it alongside your complete hormonal and metabolic picture. We don’t oversell NAD+ as a proven skin anti aging solution we present it honestly as a cellular energy and repair support tool with compelling pre clinical evidence and developing human evidence. Combined with comprehensive hormonal evaluation and personalized wellness planning, IV NAD+ is a meaningful part of a broader anti aging approach. Visit aktw.life or call (520) 710 8805.
References
- ScienceDirect / Ageing Research Reviews. (2026). NAD+ Supplementation for Anti Aging and Wellness: A PRISMA Guided Systematic Review of Preclinical and Clinical Evidence. https://www.sciencedirect.com/science/article/pii/S1568163726000498
- NMN.com. (2026). Scientists Unveil Results from Human Trial Directly Comparing Three NAD+ Precursors (Christen et al., Nature Metabolism, 2025). https://www.nmn.com/news/scientists unveil results from human trial directly comparing three nad precursors
- ScienceDaily / Chiba University. (2025). Common Supplement Reverses Premature Aging in Landmark Human Trial NR in Werner Syndrome, Aging Cell, June 2025. https://www.sciencedaily.com/releases/2025/06/250609020625.htm
- Renue By Science. (2025). NMN Outperforms NR and Other NAD+ Precursors in Skin Cells Human Fibroblast Study, October 2025. https://renuebyscience.com/blogs/scientific evidence library/nmn outperforms nr and other nad precursors in skin cells
- NMN Labo. (2026). NMN for Skin Aging: Boost NAD+ to Reduce Wrinkles Fast Evidence Review. https://nmnlabo.com/blog/nmn for skin aging/
- NCBI / PMC. (2023). The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: An Update. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721522/
- Skin Diva Labs / Financial Content Markets. (2025). NAD+ and Methylene Blue Skincare Technology Skin Aging Mechanism Review. https://markets.financialcontent.com/clarkebroadcasting.mymotherlode/article/kisspr 2025 9 18 skin diva labs unveils nad and methylene blue skincare technology
- PMC / Biogerontology. (2022). NAD+ Metabolism and Skin Aging: Current Evidence and Perspectives. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325052/
- Cleveland Clinic. (2024). NAD+ Supplements: Claims Versus Evidence. https://health.clevelandclinic.org/nad iv therapy
- National Institute on Aging / NIH. (2024). Research on NAD+ and Aging Current Status. https://www.nia.nih.gov/research/labs/aging metabolism lab
Disclaimer: This content is for informational and educational purposes only and does not constitute medical, legal, or financial advice. Reading this article does not create a patient provider relationship. NAD+ supplementation decisions should be made in consultation with a qualified healthcare provider familiar with your complete health history. For questions about AK Twisted Wellness services, visit aktw.life or call (520) 710 8805.